The in vivo regulation of T lymphocyte activity by the activation of a suicide mechanism is an essential paradigm for the safety of adoptive cell therapies. In light of reports showing that g-retroviral vector-encoded herpes simplex virus thymidine kinase (hsvtk) undergoes recombination, we undertook a thorough investigation of the genomic stability of SFG-based vectors using two variants of the wild-type hsvtk gene. In a large panel of independent clones, we demonstrate that both hsvtk genes undergo recombination with molecular signatures indicative of template switching in GC-rich regions displaying homology at the deletion junctions or RNA splicing. In the absence of ganciclovir selection, the frequency of recombination is 3% per retroviral replication cycle. Our results underscore the importance of the five nucleotide difference between the two hsvtk genes that account for the presence of recombinogenic hot spots in one variant and not the other, indicating that the probability of RNA splicing is influenced by minute nucleotide changes in sequences adjacent to the splice donor and acceptor sites. Furthermore, our mutational analysis in an unbiased panel of human lymphoid cells (that is, without immune or ganciclovirmediated selective pressure) provides a robust in vitro assay to predict and quantify clinically relevant mutations in hsvtk suicide genes, which can be applied to studying and improving the stability of any transgene expressed in g-retroviral or lentiviral vectors.
Introduction
Recombinant g-retroviruses are powerful tools in biology and medicine. To be effective, they must faithfully transmit their genetic information to the cellular host. The reliability of gene transfer is hampered by recombination events occurring during reverse transcription and other mechanisms such as RNA splicing. Single-base substitutions account for some of the errors found in the integrated viral genomes but complex recombinations involving large deletions as well as deletions with insertions have also been described in Moloney murine leukemia virus (MoMuLV)-based vectors. [1] [2] [3] [4] [5] The faithful delivery of herpes simplex virus thymidine kinase (hsvtk) is essential in gene transfer applications that require a suicide gene for safety. 6 Spurred by reports describing large deletions in integrated g-retroviral vectors encoding hsvtk 4,5,7-10 we sought to compare the genomic stability of two hsvtk variants differing by 5 bp. hsvtk1 (accession no. AY437640) is encoded in the SFG-based retroviral vector called NIT, 11 and hsvtk2 (accession no. V00467; J02224) was previously described to undergo RNA splicing in clinical vectors such as G1Tk1SvNa and SFCMM3. 7, 8 The G1Tk1SvNA and SFCMM3 vectors encode the hsvtk2 gene under the control of the MSV or MSV/MLV-LTR respectively and a selection marker (the neomycin resistance gene and the low-affinity nerve growth factor receptor (LNGF-R) gene, respectively) under the control of the SV40 promoter. 7, 8 To compare the genomic stability of hsvtk1 and hsvtk2 in the context of the same vector backbone, we constructed a retroviral vector derived from NIT called NG1 in which we have replaced hsvtk1 with hsvtk2. By using this approach, we were able to demonstrate that although both NIT and NG1 vectors undergo recombinations with molecular signatures demonstrating template switching during reverse transcription, only NG1 undergoes RNA splicing. Our results also underscore the importance of the 5 bp difference between hsvtk1 and hsvtk2 which are responsible for the activation of cryptic splice donor (SD) and splice acceptor (SA) and account for the presence of recombinogenic hot spots in hsvtk2 that do not occur in hsvtk1 nor in another previously studied hsvtk gene (hsvtk3, accession no. V00470). 5 
Results
Evaluation of the genomic stability of the SFG-based NIT vector upon selection of transduced T lymphocytes in ganciclovir In this study, our primary goal was to characterize the rate and type of mutations that occur in the hsvtk1 gene encoded in transduced cells selected on the basis of coexpression of the cell surface marker NTP, a double mutant of LNGF-R (mDLNGF-R).
11 Primary T lymphocytes transduced with NIT were treated with 1 mM GCV for 6-24 days, a dose previously shown to kill 97±4% of NIT + T cells in 4 days. 11 The results in Figures 1a and b show that, beside the wild-type PCR fragment of 882 bp, we were unable to consistently detect discrete shorter PCR products in hsvtk1-encoding NIT-transduced lymphocytes even after 24 days of culture in presence of GCV (Figure 1b, center) , nor in the genomic DNA of the PG13-NITcl.2 and PA317-G1TK 7 packaging cell lines (Figure 1b, left) . However, the same primers readily amplify a fragment of 655 bp in cells transduced with the vector G1Tk1SvNa (GMC/G1TK) even in DNA samples diluted up to 100-fold (Figure 1b, right) . We confirmed by cloning and sequencing that the 655 bp fragment was identical to the rearranged product previously described by Garin et al. 7 A third PCR fragment of approximately 800 bp was also detected and shown to be nonspecific by sequencing. We were unable to clone the shorter band that may be present in lane 3 of Figure 1b ( 7 previously detected in GMC/G1TK. GMC/G1TK cells are transduced with the G1Tk1SvNA vector that encodes the hsvtk2 gene under the control of the Moloney murine leukemia virus MSV-LTR and the neomycin resistance gene under the control of the SV40 promoter. 7 The amplification of the WT hsvtk using primers NIT12S and 14AS gives a 648 bp band and a 421 bp mutant (SD 330 -SA 554 ) band. (b) PCR analysis on genomic DNA from primary human lymphocytes PG13 cells transduced with the retroviral vector NIT and from genetically modified cells transduced with the retroviral vector G1tkSvNa (GMC/G1TK). Genomic DNA was extracted from NIT-transduced lymphocytes treated with ganciclovir (GCV) for 6-24 days (center), from the packaging cell clone PG13-NIT.cl.2 and the PA317-G1TK 7 packaging cell line (left). PCR analysis was performed using primers NIT12S and 13AS. After transduction, 10-57% of the transduced T cells were NTP + as demonstrated by fluorescence-activated cell sorting analysis using the 20.4 antilow-affinity nerve growth factor receptor (LNGF-R) monoclonal antibody (mAb). After GCV treatment, 1.3-1.4% of the T cells remained NTP + . As controls, genomic DNA from GMC/G1TK cells treated with GCV for 8 days were run in triplicate to demonstrate the reproducibility of the PCR assay (center). Genomic DNA from PA317-G1TK 7 and GMC/G1TK was kindly provided by C Ferrand, Besancon, France (left). The hsvtk WT and (SD 330 -SA 554 ) spliced mutant bands can be detected in DNA samples from GMC/G1TK cells either undiluted (1), diluted 10-fold (1:10) up to 100-fold (1:100) (right). (c) PCR analysis of genomic DNA extracted from CEM clones transduced with the retroviral vectors NIT or NG1. Genomic DNA was extracted and amplified by PCR using NIT12S and 13AS primers. All CEM clones displaying abnormal PCR amplification products as well as two representative CEM clones harboring nonrearranged NIT or NG1 vectors are shown. All these clones express the NTP cell surface marker (data not shown). (d) Hybridization blot on PCR products derived from viral RNA extracted from Phoenix-NIT bulk population (PHE NIT bulk), PG13-NITcl.2, Phoenix-NG1 bulk population (PHE NG1 bulk), PG13-NG1 bulk population (PG13-NG1 bulk) and from PG13-NG1cl.42. Viral RNA was converted to cDNA. PCR-mediated cDNA amplification was carried out using primers NIT12S and 14AS followed by hybridization blot analysis. The shorter band of 421 bp detected in Phoenix-NG1 and PG13-NG1 bulk populations and in PG13-NG1cl.42 clone was sequenced using NIT12S and 14S primers. (e) PCR analysis on genomic DNA from PG13-NITcl.2, PG13-NG1cl.42 and PG13-NG1 bulk population. PCR analysis was performed using primers NIT12S and 14AS. The shorter band of 421 bp detected in PG13-NG1 bulk population was sequenced using NIT12S and 14S primers. 
Comparison of the genomic stability of the hsvtk1 and hsvtk2 variants in the context of SFG-based g-retroviral vectors in transduced CEM cells
To compare the genomic stability of the hsvtk1 and hsvtk2 variants in identical vector backbones, we constructed an SFG-based retroviral vector derived from NIT, called NG1, in which we replaced hsvtk1 with hsvtk2 (Supplementary Figure S1 ). This approach aimed to assess if the genomic instability observed in G1Tk1SvNa is an intrinsic property of the hsvtk2 variant or if it is due to other features of the vector. Vector stocks collected from either PG13-NITcl.2 or PG13-NG1 packaging cell lines were used to transduce CEM cells. The transduced CEM cells, selected on the basis of NTP expression, 11 were cloned by limiting dilution in absence of GCV selection. Genomic DNA extracted from 98 CEM NIT + independent clones and 57 CEM NG1 + independent clones was screened by PCR amplification. The majority of the CEM clones displayed PCR amplification products of size corresponding to the nonrearranged hsvtk genes. However, 3 of 98 NIT + clones and 5 of 57 NG1 + clones displayed PCR bands of abnormal size (Figure 1c) . Some of these clones also displayed a second PCR product of the expected size, suggesting that they harbor more than one copy of the vector, as confirmed with a second set of primers (data not shown) and by Southern blot analysis (Supplementary Figure S2) . All mutant bands were cloned and sequenced. The 227 bp deletion previously demonstrated to be present in two clinical vectors (G1Tk1SvNa and SFCMM3) 11 was detected in NG1-transduced clones at a frequency of 3.3% (2 of 57) but not in NIT-transduced clones (0 of 98). The other types of rearrangements found in CEM clones transduced with either NG1 (3 of 57) or NIT (3 of 98) were deletions of 111-350 bp, combined in some cases to complex insertion/duplication mutations (Supplementary Figure S2) . Most of the mutants (7 of 8), including the NG1 (SD 330 -SA 554 ), display GC-rich regions of homology of 3-7 bp at the deletion junctions. A majority of these mutants (6 of 8) retain only one copy of the repeat after rearrangement ( Table 1) .
Comparison of the genomic stability of the hsvtk1 and hsvtk2 variants in viral RNA and genomic DNA derived from PG13-NIT and PG13-NG1 clones, and from Phoenix-NIT, Phoenix-NG1 and PG13-NG1 bulk populations
The 227 bp deletion found in NG1-transduced CEM cells was also detected by hybridization blot analysis on PCR products derived from viral RNA isolated from Phoenix-NG1 and PG13-NG1 bulk populations as well as from PG13-NG1cl.42 clone, which carries three nonrearranged copies of the NG1 vector (Supplementary Figure S5) , at a frequency of 2.1-3.7% (Figure 1d ). This result was confirmed on viral RNA derived from PG13-NG1 bulk population by labeling-PCR analysis with a frequency of 1.6% for one cycle of replication (Supplementary Figure  S4) . However, this deletion was neither detected in the viral RNA of Phoenix-NIT bulk population nor in PG13-NITcl.2 ( Figure 1d and Supplementary Figure S4) . The same 227 bp deletion was readily detectable in the genomic DNA derived from PG13-NG1 bulk population but not in the genomic DNA isolated from PG13-NITcl.2 or from PG13-NG1cl.42 (Figure 1e ) The third PCR fragment of approximately 550 bp (Figure 1d ) corresponds to the nonspecific PCR product described in Figure 1b . All the other mutations that we characterized in CEM clones were below the limit of detection in PG13-NIT or PG13-NG1 packaging cells as shown upon PCR analysis using the radiolabeled primer (Supplementary Figure S4) .
Discussion
In these studies, we identified a number of mutations and deletions in SFG-based g-retroviral vectors expressing hsvtk genes. The 227 bp deletion found in NG1-transduced CEM cells and in the viral RNA of PG13-NG1 vector stocks was previously reported to be due to the Genomic DNA from CEM clones transduced with either NIT or NG1 was amplified by PCR using either NIT12S-13AS primers and/or NIT12S-14AS primers. CEM NG1 (5 of 57) clones and 3 of 98 CEM NIT clones showed abnormal PCR bands that were cloned in pCR2.1 vector using the TOPO TA cloning kit. One or two individual pCR2.1 clones were sequenced with each set of primers (NIT12S-13AS and NIT12S-14AS). The size of the deletion, its position in the hsvtk gene, the 5 0 and 3 0 ends of the deletions, as well as the region of homology at the deletion junctions are indicated. In NG1-3, homologous base pairs on each side of the junction are in bold. a This mutation was previously described by Garin et al. 7 and displays canonical SD (CGACCAGG/gt) and SA (ag/GCCGTGC) sequences at the boundaries of the deletion. The 206 bp insertion/duplication involves a complex duplication with two repeats of the sequence CCCCAGAGCAACGCG on each side of the insertion between position 820 and 916 in the hsvtk gene.
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The other types of rearrangements found in CEM clones transduced with either NG1 or NIT were deletions of 111-350 bp, combined in some cases to complex insertion/duplication mutations. These mutations do not display any SD or SA canonical sequences at the deletion junctions. Most of the mutants, including the NG1 (SD 330 -SA 554 ), display GC-rich regions of homology of 3-7 bp at the deletion junctions, compatible with template switching at sites of direct repeats during reverse transcription. A majority of these mutants retain only one copy of the repeat after rearrangement, as previously described, and two of them show an additional G at the deletion junction. [1] [2] [3] [4] [5] 13 We found that the rate of mutation of the hsvtk gene is in the order of 3.1% in the NIT vector (3 of 98 clones) and 8.8% (5 of 57 clones) for the NG1 vector. This apparent discrepancy is consistent with the fact that NIT vector stocks are derived from the PG13-NITcl.2, which contains a single nonrearranged copy of the NIT vector. In contrast, NG1 vector stocks are derived from a population of PG13-NG1 cells that were obtained after crossinfection as described in 'Material and methods'. Therefore, the rate of mutation found in CEM cells transduced with PG13-NITcl.2 vector stocks results from a single cycle of retroviral replication which includes one round of proviral transcription in the packaging cell line by RNA polymerase II and one round of reverse transcription by the viral reverse transcriptase, whereas the rate of mutation found in CEM cells transduced with PG13-NG1 cell line results from two such cycles. The calculated rate of mutation of NG1 per cycle of replication is therefore 2.96%. These mutation rates are well in the range of previously published hsvtk gene inactivation of 3% per kbp per replication cycle in a MoMuLV-based vector, 5 indicating that our approach enabled us to capture the bulk of the deletion mutants. The deletions that were characterized in CEM clones suggest that the PCR analysis performed on the genomic DNA from bulk populations is not sensitive enough to allow the detection of rare mutants of different sizes, with the exception of the 227 bp band which is present at a higher frequency ofX1.5%. Additionally, our PCR strategy is not designed to detect point mutations, 14 very short deletions and insertions or rare deletions of the entire hsvtk-coding sequence, as recently described by Deschamps et al. 8 The latter could be detected in our assay by using PCR primers upstream and downstream of the hsvtk start and stop codons, respectively. The frequency of single point mutations inactivating the catalytic site or introducing stop codons in the hsvtk genes would have to be screened for by selection of GCVresistant clones followed by sequencing of the PCR amplification products. Importantly, we found recombinogenic hot spots at position 330 and 554 in hsvtk2, resulting in a 227 bp deletion that is undetectable in hsvtk1. This 227 bp deletion was not only found in the target CEM cell clones at a frequency of 3.3% (2 of 57), but also in the viral RNA of Phoenix-NG1 and PG13-NG1 bulk populations at an equivalent frequency of 1.6-3.7% for one cycle of replication (Figures 1d and  Supplementary Figure S4) . It was not detected in the viral RNA of PG13-NITcl.2 or Phoenix-NIT vector stocks (Figure 1d and Supplementary Figure S4) . The occurrence of the 227 bp deletion is not affected by the type of packaging cell line, as it occurs in murine PG13 and human Phoenix-eco cell lines in our studies as well as in murine PA317 cells in previous studies. 7 The frequency of this occurrence in NG1-transduced cells is lower than previously reported in CEM clones transduced with either G1Tk1SvNa (9.15%; 14 of 153 clones) or SFCMM3 (15.5%; 7 of 45 clones), and in transduced patient T cells (around 10%), 7 suggesting that other sequences in the backbone of the G1Tk1SvNa and SFCMM3 vectors or in the neomycin gene influence the rate of this deletion. The presence in the SFG vector of the SD and SA derived from the MoMuLV sequences 15, 16 may decrease the usage of the downstream cryptic SD and SA in the hsvtk sequence 17 and thus account for this difference. It is important to note that similar to hsvtk1, a third hsvtk variant (hsvtk3, V00470), studied by Parthasarathi et al., Figure S5) confirms that this deletion is due to the activation of the cryptic SD 330 and SA 554 in the context of hsvtk2. Strikingly, the absence of this deletion in the viral RNA of PG13-NIT and Phoenix-NIT packaging cells indicates that these cryptic SD and SA are not active in the context of hsvtk1.
Upon comparison of the hsvtk1, hsvtk2 and hsvtk3 sequences, it is worth noting that four out of the five nucleotides that differ between hsvtk1 and hsvtk2, at positions 427, 447, 766 and 1065, are identical between hsvtk1 and hsvtk3. It is therefore possible that one or more of these particular four nucleotides are responsible for a change in secondary structure of the hsvtk2 mRNA or for the binding of splicing factor(s) resulting in the activation of the cryptic SD 330 and SA 554 . It is thus conceivable that one or more of these nucleotides favor template switching between positions 330 and 554 during reverse transcription in hsvtk2. It was previously shown that a point mutation within CD45 exon A is the cause of variant CD45RA splicing in humans and that SR proteins are involved in the alternative process. 18 Indeed, the nucleotide change at position 427 in hsvtk2 generates a hexamer CTCATG that was recently identified as a putative exonic splicing regulatory sequence by bioinformatic analysis. 19 Further, by running this sequence in the ESEfinder, we find that the nucleotide change from A to G creates a binding site for SR proteins (SF2/ASF, SRp40 and SRp55) that does not exist in hsvtk1. 20 Alternatively, these minute sequence changes may abrogate an intron splicing silencer in hsvtk2 otherwise present in hsvtk1 and 3. 21, 22 It is noteworthy that the region of the hsvtk gene described to contain the SA 554 has been recently identified as an unusually short-sequence functioning as an internal ribosome entry site (IRES, 557-CCGUG CUGGCGU-568). 23 Although this IRES sequence is Rearrangements in retrovirally encoded hsvtk genes X Wang et al conserved between the three hsvtk variants discussed above, this secondary structure in conjunction with the nucleotide differences between the variants may be important in the appearance of a recombinogenic hot spot in hsvtk1. Indeed, template switching frequency during first-strand cDNA synthesis has been shown to be influenced by the presence of RNA secondary structures such as IRES 24 or by unpaired bases in predicted hairpin loops, bulges and stem-loops. 5, 25 Based on the fact that hsvtk1 and hsvtk3 are similar at four out of the five positions that differ between hsvtk1 and hsvtk2, we are further examining the possible involvement of these 4 bp in creating a recombinogenic hot spot in hsvtk2.
Finally, the frequency of CEM clones resistant to GCV treatment was lower than the rate of genomic rearrangements, for both NIT and NG1 vectors. Indeed, only 2% (2 of 98) and 1.7% (1 of 57) of NIT-and NG1-transduced clones, respectively, are resistant to GCV (Supplementary Figure S3) . This is consistent with half of the clones bearing more than one copy of the vector per cell (Supplementary Figure S2) . Our data in conjunction with that of others 4, 5, 7, 10 demonstrate that the genomic stability of g-retroviral vectors is affected by the vector backbones and within the same g-retroviral vector backbone, by minute sequence variations in transgene sequences. The assay described here can be used not only to determine the unbiased frequency of template switching and other rearrangements occurring in suicide genes, but also to guide the design of improved, genetically stable suicide genes, transgenes and vector backbones. In addition, it should be applicable to other retroviral vectors such as lentiviral and foamy vectors. Our study underscores the importance of prescreening combinations of transgenes and retroviral vector backbones for clinical applications.
Materials and methods
Generation of the PG13-NITcl.2, PG13-NG1cl.42, PG13-NG1, Phoenix-NIT and Phoenix-NG1 packaging cell lines SFG-NIT and SFG-NG1 plasmids encode the NTP cell surface marker, a double mDLNGF-R 11 and either hsvtk1 (AY437640) or hsvtk2 (V00467; J02224), respectively (Supplementary Figure S1) . Vector stocks obtained by transfection of the gpg29 packaging cell line 26 with the plasmid SFG-NIT 11 or SFG-NG1 were used to infect PG13 packaging cells 27 in presence of 8 mg ml À1 of polybrene. After infection, 60% of the PG13-NIT and 30% of the PG13-NG1 NTP + cell populations expressed the NTP cell surface marker as measured by flow cytometry analysis with 20.4 anti-LNGF-R-PE monoclonal antibody (mAb) (200-3-G6-4, HB-8737, ATCC, Manessas, VA, USA). PG13-NIT cell clones were isolated and titers were determined in HeLa cells under standard conditions. High-titer clones were identified by Southern blot analysis and by fluorescence-activated cell sorting analysis. The PG13-NITcl.2 clone was selected for clinical applications based on its ability to efficiently transduce primary peripheral blood lymphocytes 28 and harbors one copy of the vector as determined by Southern blot (Supplementary Figure S5) . The PG13-NG1 bulk population was enriched up to 99% NTP + using LS columns (Miltenyi Biotec GmbH, Auburn, CA, USA) with the 20.4
anti-LNGF-R mAb and goat anti-mouse immunoglobulin G microbeads (catalog no. 130-048-401). The clone PG13-NG1cl.42 was selected and harbors three unrearranged copies of the NG1 vector as demonstrated by Southern blot analysis (Supplementary Figure S5) . PG13-NITcl.2 and/or PG13-NG1 vector stocks were used to transduced primary lymphocytes and CEM cells and to extract viral RNA. Phoenix-NIT and NG1 packaging cell lines were generated by cross-infection of Phoenix-eco cells 29 with vector stocks derived from PG13-NITcl.2 and PG13-NG1 packaging cells, respectively.
Reverse transcription of viral RNA and PCR analysis of cDNA derived from PG13-NIT and PG13-NG1 vector stocks Viral RNA was extracted from 100 ml of viral supernatant from the Phoenix and PG13 packaging cell lines and was reverse transcripted to cDNA using oligo-dT primer. PCR was done using the resulting cDNAs as template with primers NIT12S and 14AS. PCR (10 ml) reaction was loaded on the gel and hybridization blot analysis was performed using 5 0 -32 P-labeled probe CCGAGCCGATG ACTTACTGGTAGGTGCTGG that anneals with nucleotides 246-275 of the hsvtk gene.
Selection of NIT-transduced T lymphocytes in ganciclovir
Peripheral blood mononuclear cells activated with PHA (Murex Diagnostics, Norcross, GA, USA; 1 mg ml
À1
) for 48 h were transduced with viral vector stocks derived from PG13-NITcl.2 and treated with 1 mM GCV for up to 24 days as previously described.
11
PCR analysis of DNA extracted from CEM clones transduced with NIT and NG1 vectors CEM cells were transduced with PG13-NITcl.2 or PG13-NG1 vector stocks and purified to 498% NTP + on LS columns using the same purification procedure as described above for PG13-NG1 cells. The NTP + CEM cells were purified and cloned by limiting dilution in the absence of GCV. Genomic DNA was extracted and analyzed by PCR and Southern blot (Figure 1c and Supplementary Figure S2 , respectively). The primer NIT12S (5 0 -GCAAGAAGCCACGGAAGTC-3 0 ), in combination with either NIT13AS (5 0 -ATCCAGGAT-AAAGAC GTGCATG-3 0 ) or NIT14AS (5 0 -CTGCAGATACCGCACC GTATTG-3 0 ), was used to amplify the hsvtk region encompassing the catalytic site of the hsvtk protein.
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